Bora inhibitors belong to a distinctive chemical class recognized for their ability to selectively target and modulate the activity of Bora, a protein crucial for cell cycle regulation and mitotic progression. Bora, also known as Bora-PP1, serves as a regulatory subunit for the Polo-like kinase 1 (Plk1), playing a pivotal role in orchestrating various cellular events during mitosis. The chemical structure of Bora inhibitors is meticulously designed to interact with specific regions of the Bora protein, often incorporating structural motifs and functional groups that facilitate precise binding.
The mechanism of action of Bora inhibitors involves their binding to the Bora protein, potentially influencing its interactions with Plk1 or other components of the cell cycle machinery. By doing so, these inhibitors can modulate the intricate network of signaling pathways associated with Bora, impacting cellular events such as centrosome maturation, mitotic entry, and cytokinesis. The design and optimization of Bora inhibitors typically involve comprehensive structure-activity relationship studies, aiming to enhance their selectivity and efficacy. The exploration of this chemical class contributes valuable insights into the fundamental processes that govern cell division and mitotic progression, unraveling the molecular intricacies that underlie normal and aberrant cellular behavior. As researchers continue to decipher the complexities of Bora inhibition, the potential applications of these compounds in advancing our understanding of cell cycle regulation and mitosis become increasingly apparent.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Alisertib (MLN8237) is a selective Aurora A kinase inhibitor. By inhibiting Aurora A kinase, Bora's function of activating Aurora A kinase would be indirectly affected. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
Tozasertib (VX-680, MK-0457) is an Aurora kinase inhibitor that can potentially affect Bora's function by inhibiting Aurora A kinase. | ||||||